CONMED Corporation Announces Third Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
CONMED (CNMD) PT Raised to $58 at Needham & Company Following 3Q Report
November 3, 2017 8:29 AM EDTNeedham & Company raised its price target on CONMED (NASDAQ: CNMD) to $58.00 (from $57.00) while maintaining a Buy rating following the company's 3Q release. Revenue was $190.1M vs. consensus of $187.1M and EPS was $0.42 vs. consensus of $0.41. lower than expected tax rate added ~$0.03 to... More
Conmed (CNMD) Tops Q3 EPS by 1c
November 2, 2017 4:19 PM EDTConmed (NASDAQ: CNMD) reported Q3 EPS of $0.42, $0.01 better than the analyst estimate of $0.41. Revenue for the quarter came in at $190.1 million versus the consensus estimate of $187.08 million.
For earnings history and earnings-related data on Conmed (CNMD) click here.
... More